Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Hogarty

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Neoplasia (New York, N.Y.)|August 7, 2025
High-dose DFMO alters protein translation in neuroblastomaAndrea T Franson, Kangning Liu, Rohan Vemu, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification SystemArlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.
American Journal of Ophthalmology|October 3, 2006
Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesionsNicholas R Mahoney, Grant T Liu, Sheryl J Menacker, et al.
Cancer Biology & Therapy|March 11, 2015
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastomaSrilatha Nalluri, Susan K Peirce, Rachel Tanos, et al.
Frontiers in Oncology|November 28, 2012
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaLaura D Gamble, Michael D Hogarty, Xueyuan Liu, et al.
Cell Death & Disease|November 16, 2023
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastomaKarolina Borankova, Maria Krchniakova, Lionel Y W Leck, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 10, 2011
Pediatric horner syndromeGrant T Liu, Nicholas R Mahoney, Robert A Avery, et al.
Cancer Research|November 20, 2002
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3Michael D Hogarty, Cynthia L Winter, Xueyuan Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological featuresTatsuro Tajiri, Xueyuan Liu, Patricia M Thompson, et al.
Cancer Biology & Therapy|June 27, 2009
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonistsBrian J Lestini, Kelly C Goldsmith, Mark N Fluchel, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Neoplasia (New York, N.Y.)|August 7, 2025
High-dose DFMO alters protein translation in neuroblastomaAndrea T Franson, Kangning Liu, Rohan Vemu, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification SystemArlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.
American Journal of Ophthalmology|October 3, 2006
Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesionsNicholas R Mahoney, Grant T Liu, Sheryl J Menacker, et al.
Cancer Biology & Therapy|March 11, 2015
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastomaSrilatha Nalluri, Susan K Peirce, Rachel Tanos, et al.
Frontiers in Oncology|November 28, 2012
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaLaura D Gamble, Michael D Hogarty, Xueyuan Liu, et al.
Cell Death & Disease|November 16, 2023
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastomaKarolina Borankova, Maria Krchniakova, Lionel Y W Leck, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 10, 2011
Pediatric horner syndromeGrant T Liu, Nicholas R Mahoney, Robert A Avery, et al.
Cancer Research|November 20, 2002
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3Michael D Hogarty, Cynthia L Winter, Xueyuan Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological featuresTatsuro Tajiri, Xueyuan Liu, Patricia M Thompson, et al.
Cancer Biology & Therapy|June 27, 2009
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonistsBrian J Lestini, Kelly C Goldsmith, Mark N Fluchel, et al.
Pageof 11